Back to all articles
pre-call planning
AI coaching
CRM data
pharma sales
HCP engagement

Pre-Call Prep That Writes Itself: How AI Turns CRM Context into Rep Confidence

David Okonkwo
13 min read
Share

There is a car park ritual that plays out across the NHS and private healthcare every day. A pharma rep pulls into a hospital car park, opens their CRM on a tablet, and scrolls through the last three call notes on the HCP they are about to see. The notes say things like "Discussed Product X. Interested but waiting for more data." or "Brief conversation in clinic. Will follow up." The rep closes the tablet, walks in, and improvises.

This is not laziness. This is what happens when preparation takes more time than the rep has. Between six to eight calls a day, driving between sites, completing compliance documentation, and attending internal meetings, there is no protected time for pre-call planning. The result is that most HCP interactions start from a lower baseline than they should. The rep is relying on memory instead of preparation. The HCP can tell.

AI-powered pre-call prep changes this equation. Instead of expecting the rep to pull together information from multiple sources, the AI does the pulling. It reads the CRM, cross-references relevant clinical data, checks the promotional material library, and produces a brief that takes two minutes to read. The rep walks in prepared, with specific context about this HCP, this conversation, and this moment.

Why most pre-call prep falls short

The problem with pre-call planning is not that reps do not understand its value. Every sales training programme emphasises preparation. The problem is that traditional pre-call planning assumes the rep has time to do research, and that the information they need is easy to find.

Neither assumption holds up in practice. A rep covering 150 HCPs across a large territory cannot spend twenty minutes preparing for each call. At best, they can scan the most recent notes and recall what they remember from the last visit, which may have been six weeks ago.

Even when reps do try to prepare thoroughly, the information is scattered. Call notes are in the CRM, where more coaching intelligence sits than most managers realise. Clinical data updates are in a separate portal. Approved messaging is in the content management system. Competitive intelligence is in a weekly email from marketing. Formulary status is in yet another system. Pulling all of this together manually for a single call is a fifteen-minute task. Doing it for every call in a day is simply not possible.

The result is a predictable pattern. Reps over-prepare for important meetings (key opinion leaders, formulary committee members) and under-prepare for routine calls. The routine calls suffer, and over time, the HCPs in those routine interactions stop seeing value in the rep's visits. Access gets harder. The rep has fewer conversations. Their territory performance declines.

What AI-powered pre-call prep looks like

An AI pre-call brief is not a data dump. It is a structured, prioritised summary that tells the rep what they need to know for this specific conversation.

A good pre-call brief includes several elements. First, relationship context: when was the last interaction, what was discussed, what commitments were made, and whether those commitments were fulfilled. This is basic but critically important. Nothing erodes credibility faster than forgetting what you promised to do. If the rep said "I will send you the long-term outcomes data" six weeks ago and never did, the brief needs to flag that before the rep walks in.

Second, clinical context: what is this HCP's specialty, what are they prescribing, what therapeutic areas are most relevant to them, and what has changed in the clinical evidence since the last visit. A cardiologist who primarily manages heart failure patients needs a different conversation from one who focuses on arrhythmias. The brief should reflect that distinction.

Third, approved messaging: based on the HCP's profile and the current promotional cycle, which approved messages are most relevant. This is particularly important in regulated industries where reps must stay within the boundaries of the approved product label. The brief can surface specific claims, supported by specific references, that are both compliant and relevant to this HCP's patient population.

Fourth, competitive context: what competitive products are gaining traction in this territory, what the competitive reps are likely saying, and where the rep's product has genuine advantages worth highlighting. This is not about attacking competitors. It is about preparing the rep to respond when the HCP says "I've been looking at Product Y."

Fifth, a suggested objective for the call. Not a script, but a clear articulation of what the rep is trying to achieve. "Advance the conversation from awareness to trial" or "Address the safety concern raised in the last visit" or "Introduce the new dosing data." A call without an objective is a call without direction.

Cardiology call vs oncology call: what changes

Pre-call briefs are not one-size-fits-all. The content and emphasis should vary based on the therapeutic area, the HCP's role, and the stage of the relationship.

For a cardiology call, the brief might focus on prescribing patterns, particularly around protocol-driven treatment pathways. Cardiologists often work within standardised guidelines (NICE recommendations, ESC guidelines), so the brief should reference where the rep's product fits within those pathways. If there has been a recent guideline update, the brief should note it. If the HCP has been prescribing a competitor that just had a label update, the brief should flag the opportunity.

A cardiology pre-call brief might read: "Dr Shah, interventional cardiologist at Royal Brompton. Last visit 23 May, discussed anticoagulation switching in AF patients post-ablation. He raised concerns about bleeding risk data in elderly patients. Since then, the 24-month subgroup analysis has been published showing no significant difference in major bleeding events for over-75s. This addresses his specific concern. Approved claim reference: UK-CAR-2026-0147. Suggested objective: share the subgroup analysis and explore whether he would consider trialling with his next eligible patient."

For an oncology call, the context is different. Oncologists tend to be research-oriented and expect reps to know the data in detail. The brief needs to be more clinically specific. It should reference the tumour types the oncologist treats, the lines of therapy where the rep's product is indicated, and any relevant conference data that has emerged since the last visit.

An oncology pre-call brief might read: "Dr Kaur, medical oncologist, specialising in NSCLC at Christie Hospital. Last visit 9 June, discussed second-line treatment options for patients who progressed on first-line immunotherapy. She asked about the overall survival update from the Phase III trial. The 36-month OS data was presented at ASCO last month and shows a median OS of 18.4 months vs 13.1 months for comparator. Full data reference and approved slide available in content library. Note: Dr Kaur is a co-investigator on the ongoing real-world evidence study. Do not discuss unpublished data from that study. Suggested objective: present the ASCO data and discuss potential fit for her current patient cohort."

The difference between these two briefs is not just therapeutic. It is about the level of clinical depth, the communication style that works best with each HCP, and the specific compliance guardrails that apply.

Compared to scrolling through Veeva in the car park

The current reality for most pharma reps is that their "pre-call prep" consists of reading the last one or two entries in their CRM while sitting in the car park. This is better than nothing, but not by much.

CRM notes are written for compliance, not for coaching. They record what happened but rarely capture why it mattered or what should happen next. A note that says "Discussed efficacy data, HCP was receptive" tells the rep almost nothing about how to advance the relationship. What efficacy data? Receptive to what specifically? What was the HCP's main concern? What would make them prescribe differently?

AI pre-call briefs extract meaning from these sparse notes by combining them with other data sources. The note might just say "discussed efficacy," but the AI knows which efficacy data was approved at that time, can infer which dataset was likely discussed, and can check whether newer data has since become available. It fills in the gaps that the rep's brief notes leave.

There is also a consistency benefit. When a different rep covers a colleague's territory during annual leave, they inherit a set of HCP relationships they know nothing about. An AI pre-call brief gives them context instantly. Instead of walking in blind and hoping the HCP does not notice that a stranger is making the call, the covering rep can reference the previous conversation, acknowledge the relationship history, and maintain continuity.

The confidence effect

Preparation drives confidence, and confidence shapes conversations. A rep who walks into a meeting knowing the HCP's prescribing habits, recent concerns, and relevant clinical updates carries themselves differently. They ask better questions. They listen more carefully because they are not mentally scrambling for something to say. They are more willing to explore the HCP's perspective because they have a solid foundation to return to.

Under-prepared reps default to product monologue. They talk because silence feels dangerous, and they stick to the features and benefits they memorised in training because they do not have enough context to personalise the conversation. HCPs can feel this. They have sat through thousands of these generic presentations. The rep who arrives prepared with specific, relevant context stands out, not because they are more charismatic, but because they are more useful.

This is particularly important for less experienced reps. A rep in their first year does not have the relationship history or territorial knowledge to improvise effectively, which is one reason daily practice accelerates quota attainment by 40%. AI pre-call briefs give them a baseline of preparation that more experienced reps build over years. It does not replace experience, but it narrows the gap.

What this does not replace

AI pre-call prep is not a substitute for knowing your product cold. A rep who does not understand the mechanism of action, the clinical trial data, or the prescribing information will not be saved by a brief, no matter how well-written it is.

It also does not replace genuine curiosity about the HCP's perspective. The brief can tell you what the HCP's concerns were last time. It cannot tell you how they are feeling today, what pressures they are under, or what has happened in their practice since your last visit. That requires active listening during the conversation, not better preparation beforehand.

And it does not eliminate the need for the rep to think critically about their approach. The brief suggests an objective. The rep should evaluate whether that objective still makes sense given what they know. Sometimes the best call plan is the one you adjust in the first thirty seconds because the HCP opens with something unexpected.

What AI pre-call prep does is remove the excuse. No rep should walk into a meeting without context when context is available at the tap of a button. The technology exists to make every call a prepared call. The question for commercial teams is whether they are willing to adopt it.

Building this into the workflow

The most effective pre-call prep systems are the ones reps do not have to go looking for. If the brief requires the rep to open a separate app, navigate to a specific screen, and request the information, adoption will be patchy. The best implementations push the brief to the rep automatically. It appears in their CRM when they open the account record. It arrives as a notification before a scheduled call. It requires zero extra effort.

Integration with existing systems matters, a point we expand on in AI coaching in the flow of work. If the brief lives outside the CRM, it becomes another tool to check. If it lives inside the workflow, it becomes part of how the rep prepares. This is a design decision, not a technology limitation, and it makes the difference between a tool that reps use every day and one that they used enthusiastically for a week and then forgot about.

Pre-call prep pairs naturally with post-call reflection: one prepares the rep for the conversation ahead, the other captures the learning from it. Together they create a continuous development loop around every field interaction.

For training teams, AI pre-call prep also creates a feedback loop. If the brief consistently surfaces gaps in the rep's knowledge (for example, the rep never discusses the health economics data, so the AI keeps recommending it), that signals a training need. The pre-call system becomes both a preparation tool and a diagnostic tool, identifying what reps need to learn next based on what they are not yet doing in the field.

Frequently Asked Questions

Share this article